These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 12948832
1. In vitro and in vivo activity of an antibacterial peptide analog against uropathogens. Cudic M, Lockatell CV, Johnson DE, Otvos L. Peptides; 2003 Jun; 24(6):807-20. PubMed ID: 12948832 [Abstract] [Full Text] [Related]
2. High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance. Wambaugh MA, Shakya VPS, Lewis AJ, Mulvey MA, Brown JCS. PLoS Biol; 2017 Jun; 15(6):e2001644. PubMed ID: 28632788 [Abstract] [Full Text] [Related]
3. Evaluation of risk factors for colistin resistance among uropathogenic isolates of Escherichia coli and Klebsiella pneumoniae: a case-control study. Kaza P, Mahindroo J, Veeraraghavan B, Mavuduru RS, Mohan B, Taneja N. J Med Microbiol; 2019 Jun; 68(6):837-847. PubMed ID: 31084700 [Abstract] [Full Text] [Related]
7. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin. Cho YH, Jung SI, Chung HS, Yu HS, Hwang EC, Kim SO, Kang TW, Kwon DD, Park K. Int Urol Nephrol; 2015 Jul 01; 47(7):1059-66. PubMed ID: 26026972 [Abstract] [Full Text] [Related]
9. In vitro activity of temocillin against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urinary tract infections in France. Duployez C, Loïez C, Cattoen C, Wallet F, Vachée A. Med Mal Infect; 2019 Feb 01; 49(1):47-53. PubMed ID: 30396720 [Abstract] [Full Text] [Related]
12. Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Titelman E, Iversen A, Kalin M, Giske CG. Microb Drug Resist; 2012 Apr 01; 18(2):189-92. PubMed ID: 22204597 [Abstract] [Full Text] [Related]
14. Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae. So W, Crandon JL, Nicolau DP. J Urol; 2015 Aug 01; 194(2):563-70. PubMed ID: 25637857 [Abstract] [Full Text] [Related]